The crystal structure of a second G protein–coupled receptor sheds light on these key pharmaceutical targets.

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...

The leaves contain several active alkaloids, primarily mitragynine and 7-hydroxymitragynine, which act as partial agonists at ...

Absence of cysteine in mice coaxed fat-storing cells to burn energy, causing weight loss and offering potential therapeutic ...

This review explores the potential of punicic acid in pomegranate seed oil as a nutraceutical for cardiovascular health.

An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR) agonist that mimics the effects of ...

G protein-coupled receptors articles from across Nature Portfolio G protein-coupled receptors (GPCRs) are integral membrane proteins with seven membrane-spanning helices. Upon binding to a ligand ...

Adrenergic function was evaluated on the basis of beat-to-beat responses in blood pressure during head-up tilting and the Valsalva maneuver.

Study met its primary and key secondary endpoints, demonstrating rapid and sustained improvement in near visual acuity; Safety profile consistent with previous clinical trials and ...

A new oral drug mimics exercise, burns fat, lowers blood sugar, and preserves muscle mass, potentially outperforming Ozempic ...

DelveInsight's Traumatic Brain Injury pipeline report depicts a robust space with 20+ active players working to develop 22+ ...

The leading Post-Traumatic Stress Disorder Companies such as Tonix Pharmaceuticals, Inc., Pop Test Oncology LLC, H. Lundbeck ...